VLife Sciences Technologies Pvt. Ltd. (VLife), a leading provider of technologies for computer aided drug and molecular discovery based in Pune, India and Computational Research Laboratories (CRL), a wholly owned subsidiary of Tata Sons Limited, based in Pune, India have reached an understanding to bring VLife’s GRIP docking technology on CRL’s high performance computing platform.

This new offering is expected to significantly reduce the time involved in conducting protein – ligand docking operations. Structure based drug design approach has traditionally been affected by limitations due to either slow or inaccurate docking activity. Researchers rarely could access a solution that was fast as well as accurate.

With the combination of VLife’s innovative GRIP technology and the computational prowess of CRL’s cluster, researchers can now conveniently access a solution to improve productivity from their structure based design efforts. With this joint offering, VLife and CRL have reinforced their commitment to address the scientific and technological challenges in the computational discovery domain on the basis of their core strengths.

About Computational Research Laboratories:
CRL, a wholly owned subsidiary of Tata Sons Ltd., is into the R&D and business of High Performance Computing (HPC) services and solutions. With ‘eka’, CRL's supercomputer (largest and fastest available in the world for scientific and commercial organizations), CRL provides an expanded portfolio of services which allows organizations to avail HPC services, without having to undergo the demands for capital expenditure and long turnaround times of cluster set up. CRL’s services and solutions are leveraged by various organizations in the automotive, aerospace, life sciences, media & entertainment, weather and scientific sectors among many others.

About VLife Sciences Technologies Pvt. Ltd.
VLife Sciences Technologies Private Limited, Pune is a leading provider of licensed software and research solutions for discovery research projects in a variety of sectors. The software offers numerous unique and specialized features for applications in computer aided molecular discovery, bioinformatics, biotechnology and chemoinformatics. Technologies developed by VLife are unique, novel and offer advantages in terms of speed and accuracy thus leading to improved outcome from discovery research projects. VLife offers the VLifeMDS^® suite for a comprehensive approach to computer aided drug design and the QSARpro^® suite for advanced quantitative structure activity relationships analysis leading to new molecule design.

For more details please visit: www.vlifesciences.com or contact us at info@vlifesciences.com